News/ News/ Oncology BMS swoops on Forbius, snaring another immuno-oncology player Phil Taylor Bristol-Myers Squibb, fibrosis, Forbius, immuno-oncology, M&A, Oncology 0 Comment With the ink barely dry on a deal to develop Dragonfly’s lead cancer immunotherapy, Bristol-Myers Squibb’s business development Share X BMS swoops on Forbius, snaring another immuno-oncology player https://pharmaphorum.com/news/bms-swoops-on-forbius-snaring-another-immuno-oncology-player/
Bristol-Myers Squibb, fibrosis, Forbius, immuno-oncology, M&A, Oncology
0 Comment
